What is the recommended treatment for streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcal Pharyngitis

Penicillin V (250 mg four times daily OR 500 mg twice daily) or amoxicillin (50 mg/kg once daily, maximum 1000 mg) for a full 10 days is the recommended first-line treatment for streptococcal pharyngitis in non-allergic patients. 1, 2

First-Line Treatment for Non-Allergic Patients

  • Penicillin V or amoxicillin remains the drug of choice due to proven efficacy, narrow spectrum, safety profile, and low cost, with no documented penicillin resistance in Group A Streptococcus anywhere in the world. 1, 2

  • Penicillin V dosing options for adults and adolescents: 250 mg four times daily OR 500 mg twice daily for 10 days 1, 2, 3, 4

  • Amoxicillin dosing: 50 mg/kg once daily (maximum 1000 mg) OR 25 mg/kg twice daily (maximum 500 mg/dose) for 10 days 1, 2

  • Amoxicillin is often preferred in children due to better palatability and once-daily dosing convenience 2

  • Intramuscular benzathine penicillin G as a single dose (600,000 units if <27 kg; 1,200,000 units if ≥27 kg) ensures compliance when adherence to oral therapy is uncertain, particularly in populations where follow-up may be lacking 2

Critical Treatment Duration

  • A full 10-day course is essential for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent acute rheumatic fever. 1, 5, 2

  • Shortening the course by even a few days results in appreciable increases in treatment failure rates and risk of rheumatic fever 5

  • Therapy can be safely postponed up to 9 days after symptom onset and still prevent acute rheumatic fever 5

Treatment for Penicillin-Allergic Patients

Non-Immediate (Non-Anaphylactic) Penicillin Allergy

  • First-generation cephalosporins are the preferred first-line alternatives for patients with non-immediate penicillin allergies, with cross-reactivity risk of less than 3-10%. 1, 5, 2

  • Cephalexin 20 mg/kg per dose twice daily (maximum 500 mg/dose) for 10 days 1, 5, 2

  • Cefadroxil 30 mg/kg once daily (maximum 1 gram) for 10 days 5, 2

  • Cross-reactivity risk is only 0.1% in patients with non-severe, delayed penicillin reactions 5

Immediate/Anaphylactic Penicillin Allergy

  • Patients with immediate hypersensitivity (anaphylaxis, angioedema, urticaria within 1 hour) must avoid all beta-lactam antibiotics including cephalosporins due to up to 10% cross-reactivity risk. 1, 5, 2

  • Clindamycin is the preferred alternative for immediate/anaphylactic penicillin allergy: 7 mg/kg per dose three times daily (maximum 300 mg/dose) for 10 days. 1, 5, 2

  • Clindamycin has approximately 1% resistance rate among Group A Streptococcus in the United States and demonstrates high efficacy even in chronic carriers 5, 2

  • Macrolides (azithromycin, clarithromycin) are acceptable alternatives but carry concerns about resistance 1, 5

Macrolide Options (When Clindamycin Cannot Be Used)

  • Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days 1, 5, 6

  • Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg/dose) for 10 days 1, 5

  • Erythromycin: 20-40 mg/kg/day divided 2-3 times daily (maximum 1 gram per day) for 10 days 5

  • Macrolide resistance among Group A Streptococcus is approximately 5-8% in the United States and varies geographically, making clindamycin more reliable in areas with high resistance rates. 1, 5

  • Azithromycin is the only antibiotic requiring just 5 days due to its prolonged tissue half-life, but data establishing efficacy in subsequent prevention of rheumatic fever are not available. 5, 6

Critical Pitfalls to Avoid

  • Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions due to 10% cross-reactivity risk. 1, 5, 2

  • Do not use tetracyclines, sulfonamides, or trimethoprim-sulfamethoxazole due to high prevalence of resistant strains or lack of efficacy. 1, 5

  • Do not prescribe shorter courses than recommended (except azithromycin's 5-day regimen) as this leads to treatment failure and complications. 1, 5

  • Do not use azithromycin as first-line therapy—it should only be used when penicillin and preferred alternatives cannot be used. 5

  • Do not assume all penicillin-allergic patients cannot receive cephalosporins—only those with immediate/anaphylactic reactions should avoid them. 5

Adjunctive Symptomatic Treatment

  • Acetaminophen or NSAIDs (such as ibuprofen) for moderate to severe symptoms or high fever 1, 5

  • Aspirin must be avoided in children due to risk of Reye syndrome. 5

  • Corticosteroids are not recommended as adjunctive therapy. 5

Follow-Up and Special Circumstances

  • Routine post-treatment throat cultures or rapid antigen tests are not recommended for asymptomatic patients who have completed therapy. 1, 5

  • Reevaluation is suggested for patients with worsening symptoms after 48-72 hours or symptoms lasting more than 5 days after treatment initiation 1

  • Do not perform diagnostic testing or empiric treatment of asymptomatic household contacts, as penicillin prophylaxis has not been shown to reduce subsequent infection rates. 1

  • Chronic carriers generally do not require antimicrobial therapy, as they are unlikely to spread infection and are at little risk for complications 5

  • For recurrent streptococcal pharyngitis or chronic carriers with multiple treatment failures, clindamycin may be particularly effective due to its ability to eradicate the organism 5, 2

References

Guideline

Treatment of Streptococcus Group C Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Group A Streptococcal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.